Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 31.01.2015

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
31.01.1511.05% CAGR for Atrial Fibrillation Market to 2019 - A Global Forecast148DALLAS, January 31, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com offers Global Atrial Fibrillation Market 2015-2019 research report of 67 pages that profiles atrial fibrillation industry...
► Artikel lesen
31.01.15Global Ink Solvents Market to see 5%+ CAGR to 201922DALLAS, January 31, 2015 /PRNewswire/ -- ReportsnReports.com adds Ink Solvents Market research report with analysis by Chemistry Type, Product Type, Process & Application and Global Forecasts to...
► Artikel lesen
31.01.15Over 7000 Industry Professionals and Leading Companies in Water to Converge at Water Philippines 201550MANILA, Philippines, Jan. 31, 2015 /PRNewswire/ -- Widely recognised as the Philippines No. 1 International Water Sanitation, Industrial Wastewater Treatment & Purification Event, 2015 will see the...
► Artikel lesen
31.01.15Auto Glass Industry 2018-2020 Market Forecasts for Global and Chinese Regions34DALLAS, January 31, 2015 /PRNewswire/ -- RnRMarketResearch.com adds latest reports on Auto Glass Industry for Global and China markets with analysis of auto glass market in china and other countries...
► Artikel lesen
31.01.15PRN_AdminLive - Test Message - Please Delete52Test Release Also by fax to Domino VSI Fax Machines 020 7570 6357, 020 7570 6358, 01865 712 083 and internal Disclose Fax: 020 7454 5182 This is a test. This is a test. This is a test. This is...
► Artikel lesen
31.01.15Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder50LEXINGTON, Massachusetts, January 30, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse® (lisdexamfetamine...
► Artikel lesen
31.01.15AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan68- 95 percent SVR12 rate achieved in Japanese patients new to therapy with genotype 1b chronic hepatitis C virus infection without cirrhosis and with a high viral load - Regulatory filing in Japan...
► Artikel lesen